is developing the LiDia-SEQ™ Platform, a direct-from-specimen diagnostic system that performs DNA sequencing on a microchip to provide rapid, actionable information to clinicians. This system is user-friendly and can work in a variety of hospital environments at the point of need. The LiDia-SEQ™ Platform has flexible levels of throughput to match a wide range of clinical demands.
DNAe’s initial focus is on infectious disease diagnostics, where speed and microbial DNA sequence information are important for the survival of the patient. This includes a range of tests, starting with a groundbreaking test for bloodstream infections (BSI) and antimicrobial resistance (AMR), which uses whole blood specimens to detect and identify infections that lead to sepsis.
Imperial researcher is the Co-Founder of DNAe
![](/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1753971163504_mainnews2012_x1.jpg")